Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026| (NASDAQ: DFTX) | Delayed: 38.92 +0.83 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.09 | 52 Week High | $ | |||
| Open | $38.00 | 52 Week Low | $ | |||
| Day High | $39.26 | P/E | N/A | |||
| Day Low | $37.70 | EPS | $ | |||
| Volume | 620,046 | |||||

